Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Persistent Pain After Breast Cancer Treatment (PPBCT) - Risk Factors and Pathophysiological Mechanisms

This study has been completed.
Danish Breast Cancer Cooperative Group
Danish Cancer Society
Information provided by (Responsible Party):
Kenneth Geving Andersen, Rigshospitalet, Denmark Identifier:
First received: January 27, 2012
Last updated: April 5, 2016
Last verified: April 2016